CoChat

Acquired Liver Injury in the Intensive Care Unit

Open access
Lescot, Thomas, Karvellas, Constantine, Beaussier, Marc, Magder, Sheldon, Riou, Bruno · 2012 · Anesthesiology
Cited by 117

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

THE liver plays a key role in the synthesis of proteins, metabolism of toxins and drugs, and in modulation of immunity. In critically ill patients, hypoxic, toxic, and inflammatory insults can affect hepatic excretory, synthetic, and/or purification functions, leading to systemic complications such as coagulopathy, increased risk of infection, hypoglycemia, and acute kidney injury. In severe cases, hepatic encephalopathy or brain dysfunction (acute liver failure) may occur. Because of the lack of specificity of standard laboratory investigations, identifying liver injury or dysfunction in critically ill patients remains a significant challenge. In addition, the great heterogeneity of criteria used to define the consequences of liver insults increases the difficulties for the clinician to properly interpret hepatic biochemical abnormalities. In this review, we choose to define liver injury as an elevation in serum concentrations of routinely measured hepatic enzymes, including aminotransferases (aspartate aminotransferase [AST]; alanine aminotransferase, [ALT]), alkaline phosphatase (ALP), or γ-glutamyl transpeptidase. Hepatic dysfunction refers to derangement of pathways related to synthetic or clearance function, including international normalized ratio (INR) and bilirubin. Hepatotoxicity refers to hepatic injury and dysfunction caused by a drug or another noninfectious agent.1Acute liver failure designates liver injury that results in life-threatening hepatic synthetic dysfunction and brain dysfunction (encephalopathy) (fig. 1). Here we review the causes, mechanisms, and clinical implications of intensive care unit (ICU)-acquired liver injury and dysfunction in patients without previous known hepatobiliary disease on ICU admission. Consequently, this review will not cover liver injury caused by chronic liver disease; viral, metabolic, vascular, or autoimmune liver disease; pregnancy-related liver injury; or postoperative hepatic resection.Despite the lack of a uniform definition, liver injury often is evaluated with routinely performed biochemistry tests, including AST, ALT, ALP, and γ-glutamyl transpeptidase. Hepatocellular injury is defined by elevation in serum aminotransferases, whereas cholestatic injury is associated with marked elevations in ALP and γ-glutamyl transpeptidase with moderate or normal elevation of serum aminotransferases. At ICU admission, these tests have been reported to be abnormal in as many as 61% of patients, correlating with short-term mortality.2Hepatocellular injury is defined by injury to hepatocytes, which can be either a reversible disturbance or cell death. It is characterized by elevation of intracellular enzymes (aminotransferases) involved in α-amino group regulation. AST and ALT are cleared in the sinusoidal cells of the liver, and serum concentrations reflect hepatocyte turnover and clearance. During liver injury, hepatocellular permeability is increased, and consequently AST and ALT are released from the intracellular space into plasma. The duration of elevation depends upon the severity of hepatic insult and the half-life of the enzyme, which ranges from 17 h for AST to 50 h for ALT.3The typical time course shows a rapid increase in serum aminotransferases followed by a slow decrease. In the ICU setting, the most common causes of hepatocellular injury are hypoxic hepatitis, congestive hepatopathy, septic shock, and drug-induced liver damage.However, in critically ill patients, an accurate interpretation of serum aminotransferase evolution remains challenging. Indeed, AST is not specific to the liver but is also produced by various tissues, such as skeletal muscles, heart, lung, brain, kidney, pancreas, erythrocytes, and leukocytes, which may release AST, especially in ICU patients with altered tissue perfusion. Conversely, ALT is expressed mainly in the liver, and normal serum ALT would exclude primary liver injury. Nevertheless, an important exception is alcoholic liver disease, for which the concentration of ALT in serum is low. This is because patients with alcoholic liver disease have a deficiency in pyridoxal-5'-phosphate, which is necessary for ALT synthesis. Consequently, the ability of serum aminotransferase to detect liver injury remains very low because massively increased liver enzymes do not adequately correlate with liver dysfunction, and of equal importance, hepatic function may be impaired with minimally increased liver enzymes.Cholestasis is defined by altered bile production, secretion, or excretion leading to a decrease or absence of bile in the duodenum. Consequently, laboratory abnormalities are related to the retention of substances in the blood that are normally excreted in bile (bile acids, conjugated bilirubin) and are associated with an increase in cholestatic enzymes such as ALP and γ-glutamyl transpeptidase. ALP is a very sensitive indicator of cholestasis. ALP is localized in hepatocytes and cholangiocytes, and usually is increased secon

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/aln.0b013e318266c6df

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 117

Metadata

Authors
Lescot, T., Karvellas, C., Beaussier, M., Magder, S., & Riou, B.
Venue
Anesthesiology
Published
2012-10-01
Volume
117
Issue
4
Pages
898-904
ISSN
0003-3022 (ISSN-L)
OpenAlex
W2039104165
Cited by
117
References
3
FWCI
1.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.